Multiple Sclerosis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knapp, C M
Right arrow Articles by Gottlob, I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knapp, C M
Right arrow Articles by Gottlob, I
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Multiple Sclerosis, Vol. 10, No. 3, 278-280 (2004)
DOI: 10.1191/1352458504ms1042oa

Serum uric acid levels in optic neuritis

C M Knapp

University of Leicester, The Leicester Royal Infirmary, Leicester, LE2 7LX, UK, cmk9{at}le.ac.uk

C S Constantinescu

University of Nottingham, Queen’s Medical Centre, Nottingham, NG7 2UH, UK

J HY Tan

University of Leicester, The Leicester Royal Infirmary, Leicester, LE2 7LX, UK

R McLean

University of Leicester, The Leicester Royal Infirmary, Leicester, LE2 7LX, UK

G R Cherryman

University of Leicester, The Leicester Royal Infirmary, Leicester, LE2 7LX, UK

I Gottlob

University of Leicester, The Leicester Royal Infirmary, Leicester, LE2 7LX, UK

Uric acid, an antioxidant, is reduced in multiple sclerosis (MS). Patients with gout have a reduced incidence of MS. O ptic neuritis (O N), often the first manifestation of MS, is not known to be associated with reduced uric acid. Patients with recent onset of O N were investigated to determine whether uric acid levels were reduced at presentatio n. Twenty-o ne patients with O N were included, 17 females and 4 males. The mean (SD) serum uric acid in the O N female group was 184.4 (±55.1) mmol/L (range, 116- 309 mmol/L), whilst in the control group it was 235.2 (±50.2) mmol/L (range, 172- 381 mmol/L). The difference was statistically significant (x2 = 8.93, P = 0.003). In the small male cohort, mean (SD) serum uric acid was 305 (±52.1) mmol/L, whilst in the control group it was 328 (±80.4) mmol/L. These differences were not statistically significant. Reduced antioxidant reserve is possibly an early patho genic mechanism in inflammatory demyelination, and raises the possibility that low uric acid levels could be an indicator of disease activity. Since optic neuropathies of other causes were not investigated, future research needs to determine whether low uric acid represents a unique feature of optic neuritis or is seen in other optic neuropathies.

Key Words: multiple sclerosis • optic neuritis • peroxinitrite • uric acid


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. K. Kutzing and B. L. Firestein
Altered Uric Acid Levels and Disease States
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. Weisskopf, E O'Reilly, H Chen, M. Schwarzschild, and A Ascherio
Plasma Urate and Risk of Parkinson's Disease
Am. J. Epidemiol., September 1, 2007; 166(5): 561 - 567.
[Abstract] [Full Text] [PDF]